Vimarsana
Biggest News Aggregation in the World

Savyon Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Savyon Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Savyon Diagnostics Today - Breaking & Trending Today

Global IVD Contract Manufacturing Industry Report - Vimarsana News

Global IVD Contract Manufacturing Industry Report

Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The

Global IVD Contract Manufacturing Industry Report 2023: A $25+ Billion Market by 2028 with Asia Pacific Emerging as the Fastest-Growing Hub - Vimarsana News

Global IVD Contract Manufacturing Industry Report 2023: A $25+ Billion Market by 2028 with Asia Pacific Emerging as the Fastest-Growing Hub

/PRNewswire/ -- The "Global IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular...

IVD Contract Manufacturing Market worth $26.7 billion by 2028 - Ucommune International (NASDAQ:UK) - Vimarsana News

IVD Contract Manufacturing Market worth $26.7 billion by 2028 - Ucommune International (NASDAQ:UK)

"The major players in the IVD contract manufacturing market include Jabil Inc. (US), Sanmina Corporation (US), TE Connectivity (Switzerland), Celestica Inc.(Canada), Savyon Diagnostics (Israel), West Pharmaceutical

Molecular Diagnostics Market worth $28.6 billion - Vimarsana News

Molecular Diagnostics Market worth $28.6 billion

/PRNewswire/ -- The molecular diagnostics industry is poised to undergo significant advancements in the near future, fueled by rapid technological innovation...

Infectious Disease Molecular Diagnostics Market is likely to reach a valuation of nearly US$ 53 bill - Vimarsana News

Infectious Disease Molecular Diagnostics Market is likely to reach a valuation of nearly US$ 53 bill

In 2021, the global Infectious Disease Molecular Diagnostics Market was estimated to be worth approximately US$ 34 billion. With a projected CAGR of 4.2% over the next ten years, the market is expected to be worth nearly US$ 53 billion by the end of 2032. Rather than the traditional methods that required pathogen cu...